Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Effective targeting of E2F1 transcription factor via siRNA gene electrotransfer in HT-29 colorectal carcinoma xenografts
ID
Jesenko, Tanja
(
Author
),
ID
Kranjc Brezar, Simona
(
Author
),
ID
Pišljar, Živa
(
Author
),
ID
Božič, Tim
(
Author
),
ID
Markelc, Boštjan
(
Author
),
ID
Cazzato, Monica
(
Author
),
ID
Grassi, Gabriele
(
Author
),
ID
Čemažar, Maja
(
Author
)
PDF - Presentation file,
Download
(4,40 MB)
MD5: D3BF949517000A3A0EE3C24A8DD1A7E8
URL - Source URL, Visit
https://www.sciencedirect.com/science/article/pii/S1567539425000970
Image galllery
Abstract
Colorectal cancer (CRC) remains a significant global health concern, with survival outcomes heavily dependent on the stage at diagnosis. Targeted therapies offer a promising approach to improve patient outcomes, particularly by addressing molecular drivers of tumor progression. One such target is the E2F1 transcription factor, a key regulator of the cell cycle and a contributor to proliferation, differentiation, apoptosis, metastasis, and chemoresistance in CRC. Previous studies have demonstrated the efficacy of E2F1 silencing via siRNA-loaded nanoliposomes in reducing tumor cell growth, but challenges such as immunogenicity and off-target effects have limited their in vivo application. In this study, we evaluated the potential of gene electrotransfer (GET) as a non-viral delivery system for delivery of therapeutic siRNA targeting E2F1 in the HT-29 CRC model. In vitro experiments showed effective silencing of E2F1 expression and a significant reduction in HT-29 cell survival. Subsequent in vivo studies confirmed the therapeutic potential of siE2F1 GET, with results demonstrating tumor growth delay, decreased proliferation, and increased necrosis in the tumors. This study establishes proof-of-principle for targeting E2F1 in CRC using GET, showcasing its versatility and therapeutic potential.
Language:
English
Keywords:
colorectal carcinoma
,
E2F1
,
gene electrotransfer
,
GET
,
silencing
,
siRNA
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
BF - Biotechnical Faculty
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
10 str.
Numbering:
Vol. 165, art. 108994
PID:
20.500.12556/RUL-169105
UDC:
616-006
ISSN on article:
1567-5394
DOI:
10.1016/j.bioelechem.2025.108994
COBISS.SI-ID:
235435267
Publication date in RUL:
12.05.2025
Views:
331
Downloads:
127
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Bioelectrochemistry
Publisher:
Elsevier
ISSN:
1567-5394
COBISS.SI-ID:
2502484
Licences
License:
CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:
The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Secondary language
Language:
Slovenian
Keywords:
kolorektalni rak
,
E2F1
,
GET
,
elektroprenos genov
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0003
Name:
Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev
Funder:
MAECI - Italy, Ministry of Foreign Affairs and International Cooperation
Project number:
VN21GR01
Funder:
Lega Italiana per la Lotta Contro I Tumori
Name:
Evaluation of a novel antifibrotic and antitumor molecule for hepatocellular carcinoma
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back